EE167 Budget Impact Analysis of Sensor Augmented Pump Therapy for Type 1 Diabetes (T1D) in Bulgaria
Sensor augmented pump (SAP) therapy combines continuous glucose monitoring (CGM) with subcutaneous insulin infusion (CSII) for the management of T1D. Evidence suggests that SAP provides better glycemic control than CSII alone. A 3-year budget impact analysis was conducted to assess the affordability of SAP therapy with PLGS algorithm for T1D in Bulgaria. (Source: Value in Health)
Source: Value in Health - December 1, 2023 Category: International Medicine & Public Health Authors: J. Yu, A.Z. Ozdemir Saltik, J. Toth, A. Dacheva, G. Slavchev, O. Cohen Source Type: research

EE47 Cost of Illness Study of Migraine in Bulgarian Patients
Migraine is an idiopathic chronic disease characterized by episodes of moderate to severe headache. Migraine is a common cause of disability and loss of work capacity. The analysis aimed to estimate the social costs and health losses associated with Migraine patients in Bulgaria. Currently, ICD code of Migraine is not included in the List of diseases paid by the NHIF in Bulgaria. (Source: Value in Health)
Source: Value in Health - December 1, 2023 Category: International Medicine & Public Health Authors: A. Dacheva, G. Slavchev, Y. Vutova, S. Djambazov Source Type: research

EE14 Cost Effectiveness of Sensor Augmented Pump Therapy with Automated Insulin Suspension in the Management of Type 1 Diabetes (T1D) in Bulgaria
This study aims to determine whether SAP therapy with PLGM algorithm is cost-effective versus CSII in people living with T1D in Bulgaria. (Source: Value in Health)
Source: Value in Health - December 1, 2023 Category: International Medicine & Public Health Authors: A.Z. Ozdemir Saltik, J. Yu, J. Toth, A. Dacheva, G. Slavchev, O. Cohen Source Type: research

EE8 Đ•conomic Evaluation of Intravascular Ultrasound (IVUS) for Imaging in Patients with Coronary Artery Disease in Bulgaria
Intravascular ultrasound (IVUS) is an imaging modality used primarily in interventional cardiology to characterize lesion morphology, quantify plaque significance, guide stent sizing, assess stent implantation, and identify procedural complications. The primary objective of this study was to perform an economic assessment of IVUS for imaging in patients with coronary artery disease in Bulgaria. (Source: Value in Health)
Source: Value in Health - December 1, 2023 Category: International Medicine & Public Health Authors: A. Dacheva, G. Slavchev, Y. Seitaridou, Y. Vutova, S. Djambazov, T. Vekov Source Type: research

Blood parameters of adult marsh frogs Pelophylax ridibundus (Amphibia: Ranidae) in rice paddies subjected to intense agrochemical use
This study was conducted in spring 2022 to assess the health status of TRF frogs compared to that of frogs occupying a reference site (RS). Furthermore, this study also compared the results obtained for the TRF population with those obtained in a study conducted at the exact same location with P. ridibundus individuals in 2013 (Zhelev et al. 2018). This comparison highlights the potential effects of persistent use of agrochemicals (pesticides and fertilizers) on the marsh frogs of later generations. Our results suggest that the general health of marsh frogs in the polluted site (PS) in southern Bulgaria has severely deteri...
Source: Environmental Science and Pollution Research International - November 30, 2023 Category: Environmental Health Authors: Zhivko Zhelev Danail Minchev Mladen Angelov Source Type: research

Blood parameters of adult marsh frogs Pelophylax ridibundus (Amphibia: Ranidae) in rice paddies subjected to intense agrochemical use
This study was conducted in spring 2022 to assess the health status of TRF frogs compared to that of frogs occupying a reference site (RS). Furthermore, this study also compared the results obtained for the TRF population with those obtained in a study conducted at the exact same location with P. ridibundus individuals in 2013 (Zhelev et al. 2018). This comparison highlights the potential effects of persistent use of agrochemicals (pesticides and fertilizers) on the marsh frogs of later generations. Our results suggest that the general health of marsh frogs in the polluted site (PS) in southern Bulgaria has severely deteri...
Source: Environmental Science and Pollution Research International - November 30, 2023 Category: Environmental Health Authors: Zhivko Zhelev Danail Minchev Mladen Angelov Source Type: research

Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria
CONCLUSIONS: Quality of life scores and the depression level are improved in RRMS patients treated with fingolimod over 2 years in real-life setting.PMID:38018696 | DOI:10.33588/rn.77s04.2023213 (Source: Revista de Neurologia)
Source: Revista de Neurologia - November 29, 2023 Category: Neurology Authors: I Milanov S Ivanova I Tournev T Chamova A Kaprelyan G Slavov V Chervenkov K Kipriyanovska Source Type: research

Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria
CONCLUSIONS: Quality of life scores and the depression level are improved in RRMS patients treated with fingolimod over 2 years in real-life setting.PMID:38018696 | DOI:10.33588/rn.77s04.2023213 (Source: Revista de Neurologia)
Source: Revista de Neurologia - November 29, 2023 Category: Neurology Authors: I Milanov S Ivanova I Tournev T Chamova A Kaprelyan G Slavov V Chervenkov K Kipriyanovska Source Type: research

Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria
CONCLUSIONS: Quality of life scores and the depression level are improved in RRMS patients treated with fingolimod over 2 years in real-life setting.PMID:38018696 | DOI:10.33588/rn.77s04.2023213 (Source: Revista de Neurologia)
Source: Revista de Neurologia - November 29, 2023 Category: Neurology Authors: I Milanov S Ivanova I Tournev T Chamova A Kaprelyan G Slavov V Chervenkov K Kipriyanovska Source Type: research

Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria
CONCLUSIONS: Quality of life scores and the depression level are improved in RRMS patients treated with fingolimod over 2 years in real-life setting.PMID:38018696 | DOI:10.33588/rn.77s04.2023213 (Source: Revista de Neurologia)
Source: Revista de Neurologia - November 29, 2023 Category: Neurology Authors: I Milanov S Ivanova I Tournev T Chamova A Kaprelyan G Slavov V Chervenkov K Kipriyanovska Source Type: research

Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria
CONCLUSIONS: Quality of life scores and the depression level are improved in RRMS patients treated with fingolimod over 2 years in real-life setting.PMID:38018696 | DOI:10.33588/rn.77s04.2023213 (Source: Revista de Neurologia)
Source: Revista de Neurologia - November 29, 2023 Category: Neurology Authors: I Milanov S Ivanova I Tournev T Chamova A Kaprelyan G Slavov V Chervenkov K Kipriyanovska Source Type: research

Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria
CONCLUSIONS: Quality of life scores and the depression level are improved in RRMS patients treated with fingolimod over 2 years in real-life setting.PMID:38018696 | DOI:10.33588/rn.77s04.2023213 (Source: Revista de Neurologia)
Source: Revista de Neurologia - November 29, 2023 Category: Neurology Authors: I Milanov S Ivanova I Tournev T Chamova A Kaprelyan G Slavov V Chervenkov K Kipriyanovska Source Type: research

Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria
CONCLUSIONS: Quality of life scores and the depression level are improved in RRMS patients treated with fingolimod over 2 years in real-life setting.PMID:38018696 | DOI:10.33588/rn.77s04.2023213 (Source: Revista de Neurologia)
Source: Revista de Neurologia - November 29, 2023 Category: Neurology Authors: I Milanov S Ivanova I Tournev T Chamova A Kaprelyan G Slavov V Chervenkov K Kipriyanovska Source Type: research

Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria
CONCLUSIONS: Quality of life scores and the depression level are improved in RRMS patients treated with fingolimod over 2 years in real-life setting.PMID:38018696 | DOI:10.33588/rn.77s04.2023213 (Source: Revista de Neurologia)
Source: Revista de Neurologia - November 29, 2023 Category: Neurology Authors: I Milanov S Ivanova I Tournev T Chamova A Kaprelyan G Slavov V Chervenkov K Kipriyanovska Source Type: research

Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria
CONCLUSIONS: Quality of life scores and the depression level are improved in RRMS patients treated with fingolimod over 2 years in real-life setting.PMID:38018696 | DOI:10.33588/rn.77s04.2023213 (Source: Revista de Neurologia)
Source: Revista de Neurologia - November 29, 2023 Category: Neurology Authors: I Milanov S Ivanova I Tournev T Chamova A Kaprelyan G Slavov V Chervenkov K Kipriyanovska Source Type: research